STAT3 Functional Defects and a Novel Therapeutic Approach for Hyper IgE Syndrome
STAT3 功能缺陷和高 IgE 综合征的新治疗方法
基本信息
- 批准号:7927739
- 负责人:
- 金额:$ 17.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-09-29
- 项目状态:已结题
- 来源:
- 关键词:Abnormal PlateletAffectAntibody FormationAntigensApoptosisBindingBlood PlateletsBreedingCell membraneCessation of lifeChimeric ProteinsComplexDNA Sequence RearrangementDefectDoseGenerationsGenesGoalsHumanImmuneIn VitroInfectionInvestigationJob&aposs SyndromeKnockout MiceLinkLymphocyteLymphocyte FunctionMegakaryocytesMembrane LipidsMissense MutationModelingMolecularMusMutationMutation AnalysisPH DomainPathway interactionsPatientsPhenotypePhosphatidylinositol 4,5-DiphosphateProtein DeficiencyProtein KinaseProteinsResearchRouteSH3 DomainsSTAT3 geneSignal TransductionSimplexvirusSite-Directed MutagenesisSystemT-LymphocyteThrombocytopeniaTyrosine PhosphorylationWiskott-Aldrich Syndromeadapter proteinbasecaspase-3in vivonovel therapeutic interventionplatelet protein P47
项目摘要
Since the identification of the gene responsible for the Wiskott- Aldrich syndrome (WAS), we have focused our research efforts on the WAS protein (WASP). The goal of this proposal is to define the molecular basis for classic WAS and its milder form, X-linked thrombocytopenia (XLT), and to study the many functions attributed to WASP in human and murine systems. Because of their central importance for the function of WASP, we have selected the pleckstrin homology (PH) domain and the SH3 binding domain of WASP for detailed analysis. Mutation analysis of patients with WAS/XLT has identified many missense mutations within the PH domain that result in XLT. PH domains are known to bind to membrane lipids (e.g., PIP2) and thus are responsible for localizing PH domain containing proteins to the cell membrane. Using an in vitro binding system, we will investigate whether naturally occurring mutations within the PH domain interfere with the binding of WASP to PIP2 and if site directed mutagenesis generates PH domains that no longer bind to PIP2. In contrast, mutations within the SH3 binding domain of WASP result in a severe WAS phenotype. Naturally occurring mutations and mutations obtained by site directed mutagenesis of the SH3 binding domain of WASP, expressed as GST-fusion proteins, will be used to demonstrate a loss of binding to SH3 containing adapter proteins and kinases known to interact with normal WASP. The effect of mutations within the PH and SH3 domain on tyrosine phosphorylation of WASP will also be investigated. Based on the observation that lymphocytes from patients with classic WAS, but not with XLT, show accelerated apoptosis and increased caspase-3 activity, we will investigate different death pathways to identify the mechanisms leading to this accelerated apoptosis. Finally, we have established a breeding colony of WAS deficient (KO) mice that will allows us to study in vivo the immune defect caused by mutations of WASP, using a T cell dependent antigen that is given at low or high doses by different routes to determine antibody responses, and an in vivo HSV infection model to study the generation of antigen-specific CTLs. The usefulness of WASP KO mice to study abnormal platelet function and accelerated apoptosis in vivo will be explored. Results from these investigations will clarify the function of WASP, explain the phenotypes of WAS/XLT and will undoubtedly have implications for optimal therapy of affected patients.
由于鉴定了负责Wiskott-Aldrich综合征(WAS)的基因,因此我们将研究工作集中在IS蛋白质(WASP)上。 该提案的目的是定义经典的分子基础,其温和形式的X连锁血小板减少症(XLT),并研究人类和鼠系统中WASP归因于WASP的许多功能。 由于它们对黄蜂功能的重要性,我们选择了pleckstrin同源(pH)域和黄蜂的SH3结合结构域进行详细分析。 对IS/XLT患者的突变分析已确定pH结构域内的许多错义突变,导致XLT。 已知pH结构域与膜脂质结合(例如PIP2),因此负责将含有蛋白质蛋白的pH结构域定位于细胞膜。使用体外结合系统,我们将研究pH结构域内的自然发生的突变是否干扰WASP与PIP2的结合,并且如果位点定向诱变会产生不再与PIP2结合的pH结构域。 相比之下,WASP的SH3结合结构域内的突变导致严重的表型。 天然存在的突变和通过位点定向的诱变(称为GST融合蛋白表示)的SH3结合结构域的定位诱变将用于证明与已知与正常WASP相互作用的含有衔接蛋白和激酶的结合丧失。 还将研究pH和SH3结构域内突变对黄蜂酪氨酸磷酸化的影响。 基于这样的观察结果,即经典患者的淋巴细胞是但没有XLT的淋巴细胞,表现出加速的凋亡和CASPASE-3活性的增加,我们将研究不同的死亡途径,以识别导致这种加速凋亡的机制。最后,我们建立了一个不足的繁殖菌落(KO)小鼠,它将使我们能够在体内研究由黄蜂突变引起的免疫缺陷,使用T细胞依赖性抗原,该抗原在低剂量或高剂量下通过不同的途径给予,以确定抗体反应,并在体内确定抗体感染模型,并在研究中研究抗基因抗原抗原蛋白酶的生成。 将探索WASP KO小鼠研究血小板功能异常和体内加速凋亡的有用性。 这些研究的结果将阐明黄蜂的功能,解释/XLT的表型,无疑将对受影响患者的最佳治疗产生影响。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TH17 cells and regulatory T cells in primary immunodeficiency diseases.
- DOI:10.1016/j.jaci.2009.03.030
- 发表时间:2009-05
- 期刊:
- 影响因子:14.2
- 作者:Ochs, Hans D.;Oukka, Mohamed;Torgerson, Troy R.
- 通讯作者:Torgerson, Troy R.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HANS D OCHS其他文献
HANS D OCHS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HANS D OCHS', 18)}}的其他基金
STUDIES OF NATURALLY OCCURRING DEFECTS IN RESISTANCE TO INFECTION
天然存在的抗感染缺陷的研究
- 批准号:
7603419 - 财政年份:2007
- 资助金额:
$ 17.89万 - 项目类别:
STUDIES OF NATURALLY OCCURRING DEFECTS IN RESISTANCE TO INFECTION
天然存在的抗感染缺陷的研究
- 批准号:
7379391 - 财政年份:2006
- 资助金额:
$ 17.89万 - 项目类别:
STUDIES OF NATURALLY OCCURING DEFECTS IN RESISTANCE TO INFECTION
天然存在的抗感染缺陷的研究
- 批准号:
7379300 - 财政年份:2006
- 资助金额:
$ 17.89万 - 项目类别:
IVGIV C W/ IGIV SOLVENT FOR IMMUNE DEFICIENCY
IVGIV C W/ IGIV 溶剂,用于治疗免疫缺陷
- 批准号:
6263557 - 财政年份:1998
- 资助金额:
$ 17.89万 - 项目类别:
SAFETY & EFFICACY OF A NEW, HEAT TREATED INTRAVENOUS IMMUNOGLOBUIN PREPARATION
安全
- 批准号:
6244278 - 财政年份:1997
- 资助金额:
$ 17.89万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
骨质疏松症骨合成代谢疗法研究转化中心
- 批准号:
10404412 - 财政年份:2023
- 资助金额:
$ 17.89万 - 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 17.89万 - 项目类别:
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
- 批准号:
10658665 - 财政年份:2023
- 资助金额:
$ 17.89万 - 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 17.89万 - 项目类别:
The role of human SLE causal variant NCF1.pR90H in promoting kidney damage
人类SLE致病变异NCF1.pR90H在促进肾脏损伤中的作用
- 批准号:
10740630 - 财政年份:2023
- 资助金额:
$ 17.89万 - 项目类别: